Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Item

http://www.wikidata.org/entity/Q34603340

Q34603340

about

Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines?Integrated genomics and metabolomics in nephrology The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice Low-protein diets in CKD: how can we achieve them? A narrative, pragmatic review Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers.Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study An observational cohort study of the kynurenine to tryptophan ratio in sepsis: association with impaired immune and microvascular function.Identification of a variable number of tandem repeats polymorphism and characterization of LEF-1 response elements in the promoter of the IDO1 gene Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites.Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human lens epithelial cells: apoptosis through the formation of 3-hydroxykynurenine.Plasma kynurenic acid concentration in patients undergoing cardiac surgery: effect of anaesthesia.Simultaneous determination of plasma creatinine, uric acid, kynurenine and tryptophan by high-performance liquid chromatography: method validation and in application to the assessment of renal function.Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma.Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS.Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress.Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia.Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite - 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.Kynurenic acid in plasma and endometrium in bitches with pyometra.Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.Induction of TDO2 and IDO2 in Liver by High-Fat Feeding in Mice: Discrepancies with Human Obesity.High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica.Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.Effect of High-Carbohydrate Diet on Plasma Metabolome in Mice with Mitochondrial Respiratory Chain Complex III Deficiency.Changes in plasma kynurenic acid concentration in septic shock patients undergoing continuous veno-venous haemofiltration.A modified HPLC method improves the simultaneous determination of plasma kynurenine and tryptophan concentrations in patients following maintenance hemodialysis.Some amino acids levels: glutamine,glutamate, and homocysteine, in plasma of children with chronic kidney disease.Beta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity.Metabolomics for clinical use and research in chronic kidney disease.The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.Heart failure and kidney dysfunction: epidemiology, mechanisms and management.Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study.Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.Feasibility of Metabolomics Analysis of Dialysate Effluents from Patients Undergoing Peritoneal Equilibration Testing.

P2860

Q26743443-0D2BA2CC-FB19-4CD3-B9D5-A74E21213B40 Q26823928-C6AB459F-9922-4074-9A7F-CEDBED156AC4 Q28382992-39D53026-B708-438A-80E4-991314458358 Q28480520-497C2FBB-7BBA-4D5B-BC83-34237D6A12C7 Q28651203-1D5FC5FE-37CE-4A9B-B5B9-1CCDA86207CD Q33585122-A8E01DC6-73D2-4E2A-860C-5991F395A9DC Q33648836-9DE9D820-96F8-4196-A3E1-52FAE1C416F9 Q33749467-1F53F920-D48A-4A1E-B8DB-43A47C4D9BAF Q33792422-3D9130A1-C459-4DC4-A310-9AA2AFDD1A6D Q33906511-EB67FE56-2BDD-4A81-9299-22C9D9DB8681 Q33952214-50CF1CE3-A4D0-401E-8B8D-B7DFB92DBA25 Q34043256-4E4C8C69-CEFE-4B31-B195-E602841819FA Q34491713-FAE5E328-DFFF-4837-887D-657E5C103003 Q34498094-6C7985CF-3FA4-4940-9A7F-BBB0CDE34A2B Q34619243-B4623802-2C65-49F2-9E1F-36554C8C2F42 Q35176244-AF3ABD85-81FC-444F-9724-EA0B8E2A9928 Q35209656-BC1979D5-2431-48D6-8E40-DF02270BD36E Q35507112-18736A5B-2BC7-46C3-BCF2-18512A06C749 Q35600812-45F5E77F-8041-48CC-A950-1E8405CD0A66 Q35883201-8CF1787A-396C-416C-837B-E83BEEFE7131 Q35988407-A54C7865-F0A2-40B8-99C5-B9EB48CCB1A3 Q36077694-3FFEF444-B3D0-4C2E-9DBC-8090BAF1A33B Q36155291-029317EB-4EDC-4F22-BB9E-604DC85BE7C3 Q36189171-A72C2077-70A4-4BEF-B827-730AFF97328F Q36554693-9871EB87-629F-4D6F-8A98-8B7F06144455 Q37013795-1C51E990-9648-400E-A93C-6673B7C270DB Q37059599-31ADE0A0-5F21-40A0-B5AB-8EDDECA63FEA Q37416875-4678C391-72E0-48F1-8CC2-B051B2E1392B Q37426982-0AD19767-25EB-4379-90F4-D77435274415 Q37465457-4EBDC583-63F4-4DB6-8AB3-503E298E5DB5 Q37592913-62CCA434-4AEB-4924-BB25-C304C356CA05 Q37652119-7E138359-F162-438C-A9E6-A22961CF7198 Q37685891-001FDFA1-F8C2-4B66-ACB9-852A96BC9F83 Q37690195-ACA6A553-FEE7-4C62-93C0-88AA10812B8A Q38750287-7B47E403-A4DC-4368-BA63-A9E50149C3CA Q38793765-BC5E491A-1D6E-4854-BE21-7CB85FE59FD1 Q38826590-2D1AEB51-5B54-4CF0-BFD7-31AC4BCB23AB Q39085572-5213FFA6-0CA2-4CA5-B5EC-3B8A8B04B0AC Q40241262-771DAF05-3092-43D3-99C1-BFC2BD94000D Q41109631-F5177C12-359C-4AF2-938A-434D258E8ED8

P2860

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Item

http://www.wikidata.org/entity/Q34603340

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu